1. New Trends in Bladder Cancer Management
Jacques Irani, Nicolas Mottet, María Jose Ribal Caparrós, Pierre Teillac 
European Urology Supplements 
Volume 6, Issue 4, Pages (March 2007)
DOI: /j.eursup
Copyright © 2007 European Association of Urology Terms and Conditions

2. Fig. 1
Survivin expression increases gradually with advancing pathologic stage and primary transitional cell carcinoma (TCC) and is highest in lymph node metastases [6]. CIS=carcinoma in situ.
European Urology Supplements 2007 6, DOI: ( /j.eursup )
Copyright © 2007 European Association of Urology Terms and Conditions

3. Fig. 2
Sensitivity and specificity of nuclear matrix protein 22 (NMP22) and voided urine cytology (VUC) reported in three different studies [9–11].
European Urology Supplements 2007 6, DOI: ( /j.eursup )
Copyright © 2007 European Association of Urology Terms and Conditions

4. Fig. 3
Sensitivity and specificity of NMP22, voided urine cytology (VUC), washing cytology (WC), and fluorescence cystoscopy (FLC) [9].
European Urology Supplements 2007 6, DOI: ( /j.eursup )
Copyright © 2007 European Association of Urology Terms and Conditions

5. Fig. 4
Patients with recurrent bladder cancer after 12 mo of remission have similar cancer-free survival rates after treatment with Bacillus Calmette-Guérin (BCG)+interferon-α (IFN-α) as BCG-naïve (BCG-N) patients [13]. * versus BCG-N patients.
European Urology Supplements 2007 6, DOI: ( /j.eursup )
Copyright © 2007 European Association of Urology Terms and Conditions

6. Fig. 5
Adjusted bladder cancer index (BCI) domain scores by localised bladder cancer treatment [26]. *p<0.001 versus all other treatment groups; **p<0.005 versus cystectomy groups; ***p<0.01 versus cystectomy groups. Rx=therapy.
European Urology Supplements 2007 6, DOI: ( /j.eursup )
Copyright © 2007 European Association of Urology Terms and Conditions

7. Fig. 6
Tumour necrosis is a prognostic indicator in upper urinary tract tumours. p<0.001 (log-rank test) [28].
European Urology Supplements 2007 6, DOI: ( /j.eursup )
Copyright © 2007 European Association of Urology Terms and Conditions